# Study to Evaluate Safety and Activity of Inhaled TRL1068 in Healthy Volunteers

> **NCT07644195** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Trellis Bioscience LLC** · enrollment: 14 (estimated)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** TRL1068, a human monoclonal antibody

## Key facts

- **NCT ID:** NCT07644195
- **Lead sponsor:** Trellis Bioscience LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2026-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07644195

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07644195, "Study to Evaluate Safety and Activity of Inhaled TRL1068 in Healthy Volunteers". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07644195. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*